As reported in the June 11, 2014 Avalere study examining cost sharing in silver exchange plans, many drugs for patients with chronic conditions enrolled in silver exchange plans are priced as to be unaffordable, creating access barriers for many patients for whom the landmark Affordable Care Act was particularly designed. This study exposes a genuine flaw in a key part of the Act which especially impacts the 25 percent of enrollees in exchanges who are between the ages of 55 and 64. People as they age find their prescription drug costs rise, in part due to increases in chronic conditions.
The dramatic cost shifting to vulnerable populations that is taking place within the Health Insurance Exchanges is troubling. The Oncology Nursing Society (ONS) believes that access to cancer care is the right of all people. While the Affordable Care Act (ACA) expanded access to insurance coverage, unaffordable co-insurance payments continue to threaten access to cancer care.